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SMAAbstract Melittin, the main bee venom component, has many positive biological effects and a rel-
atively low toxicity in various cell types. However, there is no evidence of the effect of melittin on
gastrointestinal cells. In the present study, we investigated the histological and immuonohistochem-
ical effects of melittin on mice stomach. Adult male mice (Albino Swiss) were randomly divided into
two groups (7 mice for each group): control group and melittin only treated group (10 and 40 lg/
kg). These mice were sacriﬁced, then samples from the stomach were collected and prepared for his-
topathological studies by using alcian blue stain and immuonohistochemical studies by using
smooth muscle actin (SMA) antibody. Treatment with melittin alone do not cause any harmful
effect on the stomach tissue where the microscopic examination of Alcian blue stained section
showed the normal distribution of the mucous secreting cells of the stomach tissues. On other hand,
no changes were observed on smooth muscle cells. This study demonstrated the safety of using mel-
ittin on gastrointestinal tissues if used in deﬁnite dose and for suitable duration, which offers an
opportunity for its use as a treatment for many diseases of the gastrointestinal tract.
ª 2014 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Melittin has many positive biological effects and a relatively
low toxicity (Raghuraman and Chattopadhyay, 2004). In the
central and peripheral nervous system, it stimulates many
peripheral chemoreceptors, blocks transmission of the vegeta-tive synapse and the polysynaptic neuronal paths, and
increases brain blood circulation, inﬂuence of behavior pat-
terns, pain-soothing and has cholinolytic action (against ace-
tylcholine) (Shkenderov and Ivanov, 1983; Karimi et al.,
2011). In the cardiovascular system, melittin increases coro-
nary and peripheral blood circulation, improves the microcir-
culation of blood in the tissues, slows down heart at lower
doses and stimulates it at higher ones and lowers blood pres-
sure. Melittin acts against blood coagulation (ﬁbrinolytic),
stimulates the building of erythrocytes and improves the regen-
eration of leucocytes and erythrocytes. Also it is antiarrhyth-
mic (Yalcin et al., 2009). In the endocrine system, melittin
increases secretion of thyroid, hypophysis and the hypothala-
mus hormones, plasma adrenaline, noradrenaline, vasopressin
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Savci, 2007). In the immune system, melittin has an immuno-
suppressive and immunoactivating action(Son et al., 2007).
Melittin also has antibiotic, fungicidal, antiviral and bacterici-
dal action against different pathogens such as Candida albi-
cans, and inactivation of Herpes, Leukemia and HIV viruses
(Conlon et al., 2003). In addition, melittin has metabolic
effects, where it increases the protein and nucleotide metabo-
lism (Conlon et al., 2003).
In contrast, high concentrations of melittin exhibited a vari-
ety of toxic effects such as lysis of the eukaryotic cells (Klocek
and Seelig, 2008) through increasing cell membrane permeabil-
ity to ions and stimulating the activity of phospholipase A2
(Mollay and Kreil, 1974), inhibition of (H+, K+) ATPase
(Cuppoletti et al., 1989; Cuppoletti and Abbott, 1990) and
inhibition and aggregation of the membrane proteins (Clague
and Cherry, 1988; Mahaney and Thomas, 1991). It also
inhibited mitochondrial respiration due to disturbances of
membrane and organized respiration complexes (Shkinev
et al., 1978). Injection of melittin also induced spontaneous
pain, increased blood ﬂow (neurogenic inﬂammation) as well
as the appearance of regions of hyperalgesia around the site
of injection (Sumikura et al., 2003).
In the gastrointestinal GI tract, melittin is a potential perme-
ability enhancer and transiently increases intestinal permeabil-
ity. It also exhibits necrotic cytotoxicity in the gastrointestinalTable 1 Alcian blue stainability in tissues of the body of the stoma
Control group Melittin groups
10 lg/kg
3D 5D
Gastric pits +++ +++ ++
Gastric glands +++ +++ ++
(++++): Highly intense stainability.
(+++): Intense stainability.
(++): Moderate stainability.
(+): Weak stainability.
Figure 1 Transverse section in the body of the stomach of a control m
cells of the gastric pits (arrows) that positively reacted with Alcian
previous ﬁgure in which the mucous secreting cells of the gastric pits
X400).cells (Maher et al., 2007). In the gastric mucosa, melittin de-
creased the nutrient membrane’s partial conductance of Cl,
K+, and Na+, as well as the secretory membrane partial
conductance of Cl, without affecting the secretory partial con-
ductance of Na+ or K+ (Carrasquer et al., 1998). Low concen-
trations of melittin were not cytotoxic in both cell and tissue
structures, although it caused an increase in paracellular perme-
ability in themucosal epithelium (Maher et al., 2007). It has also
been reported that melittin did not affect the cellular functions
such as mucus secretion (Maher and McClean, 2006). There-
fore, low doses of melittin may be used in therapeutic delivery
of oral preparations (Maher et al., 2007). In contrast, high con-
centrations of melittin have multiple mechanisms of toxicity
including cytolytic activity, where itmay cause a necrotic change
and loss of plasmamembrane integrity (Masquelier et al., 2004).
Melittin can also increase gastrointestinal permeability, being
especially effective in the colon (Maher et al., 2007). There are
several reports on the interaction of melittin with the epithelial
cell structure and function including pathways which are linked
with paracellular permeability (Maher et al., 2007).
Long term melittin treatment resulted in a loss of microvilli,
an increase in cell debris and destruction of intestinal tight
junctions and cell–cell adhesion (Tosteson et al., 1985). In
intestinal enterocytes and goblet cells, melittin led to a reduc-
tion in cell viability associated with necrotic cell death, and in-
creased mucus secretions (Maher et al., 2007; Maher andch in control and experimental groups.
40 lg/kg
10D 3D 5D 10D
+ +++ +++ ++ +
+ +++ +++ ++ +
ouse (A) showing the normal distribution of the mucous secreting
blue (Alcian blue, X100); (B) showing high magniﬁcation of the
(arrows) display positive reactivity with Alcian blue (Alcian blue,
Figure 2 Effect of melittin (10 lg/kg) on the stomach body. (A) Transverse section in the body of the stomach of a mouse treated with
melittin (10 lg/kg) for 3 days showing more or less normal presence of the positively reacted mucous secreting cells of gastric pits (arrows)
and a few gastric glands (double arrows) (Alcian blue, X100). (B) Transverse section in the body of the stomach of a mouse treated with
melittin (10 lg/kg) for 3 days showing mucous secreting cells of the gastric pits (arrows) and the gastric glands (double arrows) which are
positively reacted with Alcian blue (Alcian blue, X400). (C) Transverse section in the body of the stomach of a mouse treated with melittin
(10 lg/kg) for 5 days showing positive reactivity with Alcian blue at the mucous secreting cells of a number of gastric pits (arrows) and
gastric glands (double arrows) (Alcian blue, X100). (D) Transverse section in the body of the stomach of a mouse treated with melittin
(10 lg/kg) for 5 days showing enlarged part of the previous ﬁgure in which the gastric pits (arrows) display more or less normal presence of
the mucous secreting cells that react with Alcian blue (Alcian blue, X400). (E) Transverse section in the body of the stomach of a mouse
treated with melittin (10 lg/kg) for 10 days showing gastric pits (arrows) and gastric glands (double arrows) that contain mucous secreting
cells positively reacted with Alcian blue (Alcian blue, X100). (F) Transverse section in the body of the stomach of a mouse treated with
melittin (10 lg/kg) for 10 days showing a higher magniﬁcation of gastric pits (arrows) lined by mucous secreting cells that positively
reacted with Alcian blue. Double arrow: Positively reacted gastric glands (Alcian blue, X400).
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Figure 3 Effect of melittin (40 lg/kg) on the stomach body. (A) Transverse section in the body of the stomach of a mouse treated with
melittin (40 lg/kg) for 3 days showing positive reactivity with Alcian blue at the mucous secreting cells of the gastric pits (arrows) and gastric
glands (double arrows) (Alcian blue, X100). (B) Transverse section in the body of the stomach of a mouse treated with melittin (40 lg/kg) for
3 days showing an enlarged part of the previous ﬁgure that displays positively reacted mucous secreting cells of the gastric glands (double
arrows) (Alcian blue, X400). (C) Transverse section in the body of the stomach of amouse treated withmelittin (40 lg/kg) for 5 days showing
less Alcian blue reactivity of the mucous secreting cells of gastric pits (arrows) compared to those of the control sections (Alcian blue, X100).
(D) Transverse section in the body of the stomach of a mouse treated with melittin (40 lg/kg) for 5 days showing weak reactivity of the
mucous secreting cells at the gastric pits (arrows) and the gastric glands (double arrows) (Alcian blue, X400). (E) Transverse section in the
body of the stomach of a mouse treated with melittin (40 lg/kg) for 10 days showing weak reactivity with Alcian blue at a few mucous
secreting cells within the gastric glands (double arrows) and a few numbers of gastric pits (arrows) (Alcian blue, X100). (F) Transverse section
in the body of the stomach of a mouse treated with melittin (40 lg/kg) for 10 days showing an enlarged part of the previous ﬁgure which
displays weak reactivity of the mucous secreting cells at a few gastric pits (arrows) (Alcian blue, X400).
102 O. Abu-Zinadah et al.McClean, 2008). This production of mucus in the GI tract may
potentially reduce the effects of melittin on permeationenhancement (Behrens et al., 2002). These aspects of melittin
activity and its ability to disrupt the integrity of the cell
Effect of melittin on mice stomach 103membrane may be involved in the peptide cytotoxicity which is
considered as a limiting factor in the use of melittin in infec-
tious disease (Maher and McClean, 2006).
2. Materials and methods
2.1. Melittin
Melittin (the principle hemolytic component of honeybee
venom) was obtained from Sigma Chemical Company in the
form of a powder. 0.135 g of melittin was dissolved in 100 ml
of distilled water. Melittin solution was divided into small ali-
quots that were kept frozen (20 C) until the time of use. The
solution was diluted to prepare the required concentrations (10
and 40 lg/kg body weight).
2.2. Experimental animals
Adult male Albino mice (25 ± 5 g) were kindly supplied by
The Animal House of King Fahd Medical Research Center,
King Abdulaziz University, Jeddah. The mice were transferred
to wire-bottomed cages at the animal house of King Fahd
Medical Research Center. The animals were kept at an ambi-
ent temperature and fed on a special rodent diet supplied byTable 2 Immunohistochemical reactivity of the smo
stomach body.
Group Mu
Control group ++
Melittin group (10 lg/kg) for 3 days ++
Melittin group (10 lg/kg) for 5 days ++
Melittin group (10 lg/kg) for 10 days ++
Melittin group (40 lg/kg) for 3 days ++
Melittin group (40 lg/kg) for 5 days ++
Melittin group (40 lg/kg) for 10 days ++
(+) Weak reactivity.
(+±) Moderate to weak reactivity.
(++) Moderate reactivity.
(+++) Intense reactivity.
Figure 4 Transverse section in the body of the stomach of a control m
the muscularis mucosa (arrow head) and the muscularis externa (double
higher magniﬁcation of the muscularis externa (double arrow heads)
reactivity (SMA immunohistochemistry, X400).Medical Professions for the Veterinary Products and Fodders
Additions Company (MUVCO). The mice were given fresh
water through glass bottles with a capillary dropper ﬁxed to
the wall of the cage in a position to be available for the mice.
Water was changed and the cages were cleaned every day. The
mice were weighted just before the beginning of each
experiment.
2.3. Experimental groups
2.3.1. Control group
The control group included seven adult male Albino mice.
Each mouse was treated by using the stomach feeding tube
with a daily dose of 1 ml distilled water for ten days.
2.3.2. Melittin group
Forty-two mice were divided into six subgroups (7 mice each)
and treated by using the stomach feeding tube as follows: The
ﬁrst three subgroups were treated daily with a melittin (10 lg/
kg body weight) for 3, 5 or 10 days, while the others were
treated daily with a single dose of melittin (40 lg/kg body
weight) for 3, 5 or 10 days. Melittin doses have been selected
on the basis of preliminary experiments in order to ﬁnd out
the safe dose to be used in the stomach tissue.oth muscle actin (SMA) antigen at tissues of the
scularis mucosa Muscularis externa
+ +++
+ +++
+ +++
+ +++
+ +++
+ +++
+ +++
ouse (A) showing intense smooth muscle actin (SMA) reactivity at
arrow heads) (SMA immunohistochemistry, X100); (B) showing a
and muscularis mucosa (arrow head) that displays intense SMA
Figure 5 Effect of melittin (10 lg/kg) on the stomach body. (A) Transverse section in the body of the stomach of a mouse treated with
melittin (10 lg/kg) for 3 days showing intense reactivity of SMA at the muscularis mucosa (arrow head) and muscularis externa (double
arrow heads) (SMA immunohistochemistry, X100). (B) Transverse section in the body of the stomach of a mouse treated with melittin
(10 lg/kg) for 3 days showing a high magniﬁcation of the muscularis mucosa (arrow head) and muscularis externa (double arrow heads)
which displays intense reactivity with SMA (SMA immunohistochemistry, X400). (C) Transverse section in the body of the stomach of a
mouse treated with melittin (10 lg/kg) for 5 days showing intense reactivity of SMA at the muscularis mucosa (arrow head) and the
muscularis externa (double arrow heads) (SMA immunohistochemistry, X100). (D) Transverse section in the body of the stomach of a
mouse treated with melittin (10 lg/kg) for 5 days showing an enlarged part of the previous ﬁgure in which the muscularis externa (double
arrow heads) reveals intense SMA reactivity. LM: Longitudinal muscles; CM: Circular muscles (SMA immunohistochemistry, X400). (E)
Transverse section in the body of the stomach of a mouse treated with melittin (10 lg/kg) for 10 days showing muscularis mucosa (arrow
head) and muscularis externa (double arrow heads) that intensely reacted with SMA (SMA immunohistochemistry, X100). (F) Transverse
section in the body of the stomach of a mouse treated with melittin (10 lg/kg) for 10 days showing an enlarged part of the muscularis
externa (double arrow heads) and the muscular mucosa (arrow head) that intensely reacted with SMA (SMA immunohistochemistry,
X400).
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Figure 6 Effect of melittin (40 lg/kg) on the stomach body. (A) Transverse section in the body of the stomach of a mouse treated with
melittin (40 lg/kg) for 3 days showing intense reactivity with SMA at the muscularis mucosa (arrow head) and the muscularis externa
(double arrow heads) (SMA immunohistochemistry, X100). (B) Transverse section in the body of the stomach of a mouse treated with
melittin (40 lg/kg) for 3 days showing an enlarged part of the muscularis externa (double arrow heads) that displays intense SMA
reactivity. Note intensely reacted muscularis mucosa (arrow head). LM: Longitudinal muscles; CM: Circular muscles (SMA
immunohistochemistry, X400). (C) Transverse section in the body of the stomach of a mouse treated with melittin (40 lg/kg) for
5 days showing the muscularis mucosa (arrow head) and the muscularis externa (double arrow heads) with intense SMA reactivity (SMA
immunohistochemistry, X100). (D) Transverse section in the body of the stomach of a mouse treated with melittin (40 lg/kg) for 5 days
showing an enlarged part of the muscularis externa (double arrow heads) with intense SMA reactivity. LM: Longitudinal muscles; CM:
Circular muscles (SMA immunohistochemistry, X400). (E) Transverse section in the body of the stomach of a mouse treated with melittin
(40 lg/kg) for 10 days showing intense reactivity with SMA at the muscularis mucosa (arrow head) and the muscularis externa (double
arrow heads) (SMA immunohistochemistry, X100). (F) Transverse section in the body of the stomach of a mouse treated with melittin
(40 lg/kg) for 10 days showing an enlarged part of the previous ﬁgure which displays intense SMA reactivity at the muscularis externa
(double arrow heads) (SMA immunohistochemistry, X400).
Effect of melittin on mice stomach 105After 24 h from each treatment, mice from all groups were
sacriﬁced under light ether anesthesia. Samples from thestomach body collected from all animals were prepared for his-
tological and immunohistochemical studies.
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ately removed from each animal and then washedwithin a phys-
iological saline solution (0.85% NaCl) for the removal of the
blood or food remnants, whichmight obstruct the process of ﬁx-
ation. Small pieces (about 4 mm in diameter) from each sample
were obtained by using a sharp blade. Tissue samples were al-
lowed to remain in the ﬁxative (10% neutral buffered formalin)
for 24 h. The ﬁxed samples were washed overnight under run-
ning water, then dehydrated through ascending series of ethyl
alcohol (30%, 50%, 70%, 80%, 90%, 95%, and 2 changes of
100%) for 2 h each.
Clearing was next by moving the tissues into a mixture of
absolute ethanol and toluene (1:1) for 2 h, then in two changes
of pure toluene (2 h each). Tissue samples were then placed
into a mixture of toluene and parafﬁn (1:1) in the oven. The
tissues were then inﬁltrated in pure parafﬁn and embedded
in parafﬁn block by using Parafﬁn Embedding Machine (LS-
100; Bio-Equip Company). The blocks were allowed to cool
slowly in a water bath (20–25 C).
Parafﬁn blocks were trimmed for removing excess parafﬁn
around the tissue samples by using a sharp blade. The parafﬁn
blocks were sectioned at a thickness of ﬁve microns by using a
rotating microtome (Bright instrument LTD, England) at the
Histology Unit of Anatomy Department, Faculty of Medicine,
King Abdul-Aziz University. The parafﬁn sections were
ﬂoated over a warm water bath and picked up by clean glass
microscopic slides, which contained glycerin Mayer’s adhesive
media (egg albumin + glycerin + sodium salicylate). The
slides were placed in a warm oven at 25 C for about 15 min.
2.4. Techniques
The parafﬁn sections were used in the following techniques:
2.4.1. Alcian blue technique
Alcian blue staining technique was used to detect acid muco-
substances and acetic mucins in different mucous secreting
cells of the stomach (Sheehan and Hrapchak, 1980; Bancroft
and Stevens, 1982).
2.4.2. Immunohistochemical (IHC) techniques
Immunohistochemical staining is a valuable tool for detecting
speciﬁc antigens in tissues (Cuello, 1993). The Smooth Muscle
Actin (SMA) (obtained from Ventana Company) was used in
the present study as a primary antibody to detect Muscle Actin
marker mouse monoclonal antibody.3. Results
3.1. Alcian blue-stained sections
Alcian blue stain was applied for the detection of the mucous
secreting cells in the gastric tissues of the control and experi-
mental groups (Table 1).
3.1.1. Control group
In sections of the stomach body of control mice, the mucous
secreting cells of the gastric pits and the gastric glands showed
a strong stainability with Alcian blue indicated by blue color-
ation at these cells (Fig. 1A and B).3.1.2. Melittin treated group
Treatment with 10 lg/kg melittin for 3 days (Fig. 2A and B),
5 days (Fig. 2C and D) or 10 days (Fig. 2E and F) showed more
or less normal presence of positively stained mucous secreting
cells of the gastric pits and the gastric glands similar to those of
the control group.
After treatment with 40 lg/kg melittin for 3 days, the body
of the stomach showed positive stainability with Alcian blue at
the mucous secreting cells of the gastric pits and the gastric
glands (Fig. 3A and B). However, after treatment with the
same dose of melittin for 5 days less Alcian blue stainability
was displayed by the mucous secreting cells of the gastric pits
and the gastric glands compared to those of the control group
(Fig. 3C and D). Weak stainability with Alcian blue at a few
mucous secreting cells within the gastric glands and a few num-
bers of gastric pits were observed after 10 days of treatment
with the same dose of melittin (Fig. 3E and F).
3.2. Immunohistochemical reactivity of the smooth muscle actin
(SMA) antigen
The immunohistochemical reactivity of the smoothmuscle actin
(SMA) antigen, the speciﬁc antigen of the smooth muscle ﬁbers,
was indicated by a brown coloration at the smooth muscles of
the muscularis mucosa and the muscularis externa of the stom-
ach body tissues of control and treated mice. SMA reactivity of
different smooth muscles is summarized in Table 2.
3.2.1. Control group
Microscopic examination of sections of the stomach body
from control mice showed intense SMA reactivity at the mus-
cularis mucosa and the muscularis externa (Fig. 4A and B).
3.2.2. Melittin treated group
The stomach body of mice treated with 10 lg/kg melittin for
3 days showed intense SMA reactivity at the muscularis muco-
sa and muscularis externa (Fig. 5A and B). Similar results were
recorded in the muscularis mucosa and muscularis externa of
the stomach body in mice treated with the same dose of melit-
tin for 5 days (Fig. 5C and D) or 10 days (Fig. 5E and F).
Treatment of mice with 40 lg/kg melittin also showed in-
tense SMA reactivity at the muscularis mucosa and the muscu-
laris externa after 3 days (Fig. 6A and B), 5 days (Fig. 6C and
D) or 10 days (Fig. 6E and F) of treatment.
4. Discussion
In this research we investigated the histological and immuono-
histochemical effects of melittin on mice stomach, where there
is no evidence of the effect of melittin on gastrointestinal cells.
The microscopic examination of Alcian blue stained section
showed the normal histological features of the four layers, and
the distribution of the mucous secreting cells of the stomach tis-
sues. From previous results, it is obvious that both doses of mel-
ittin (10 and 40 lg/kg) have no harmful effects on the
histological structure of the stomach tissues. These ﬁndings
agree with those of Maher et al. (2007) who informed that mel-
ittin at low concentrations did not induce any cytotoxicity in the
intestinal tissues of rats and did not affect their cellular functions
such as mucus secretion. Our ﬁnding is also similar to Yun et al.
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ittin (10 and 50 lg/kg) displayed typical histological structure,
and that these doses were safe on the tissue. In this study, the
immunohistochemical detection of Smooth Muscle Actin
(SMA) antigen was used to determine the effect of melittin on
smooth muscle ﬁbers of the muscularis mucosa and the muscu-
laris externa (properia) of stomach tissues, where the SMAplays
an important role in the regulation of Ca2+ sensitivity since it
induced an increase in the intracellular calcium (Bitar, 2003).
Prakash et al. (2010) added that SMA is related to the contractile
and the cytoskeletal functions in various types of cells, where it
serves to facilitate cell contraction and migration. The results of
the present study showed that no changes were observed on the
reactivity of SMA inmice tissues treatedwithmelittin conﬁrmed
the safety effects and the protective role of melittin. Further-
more, Son et al. (2006) andYun et al. (2011) supported our ﬁnd-
ing by explaining the protective effect of melittin against the
abnormal cases of smooth muscles including ***increasing the
growth of smooth muscle cells besides the signiﬁcant inhibition
on the proliferations of the smooth muscle cells through induc-
ing apoptosis to the proliferating cells, thus lead to regulation of
the smooth muscle contractility.
5. Conclusion
This project concluded that the use of melittin in a speciﬁc
dose and for certain duration is safe on gastrointestinal tissues
and does not have any cytotoxic effects on the tissues and cel-
lular function such as mucus production of the living organ-
ism, These ﬁnding push the studies one step further toward
the therapeutic effect of melittin as a treatment for many dis-
eases of the gastrointestinal tract.Acknowledgements
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